Literature DB >> 7000762

Biosynthesis of HLA-A and HLA-B antigens in vivo.

M J Owen, A M Kissonerghis, H F Lodish.   

Abstract

The biosynthesis of the HLA-A and -B antigens was studied in the B lymphoblastoid cell line BRI 8 and the Burkitt lymphoma line DAudi. The heavy chains of the HLA-A and -B antigens were inserted asymmetrically into the rough endoplasmic reticulum of BRI 8 cells as transmembrane polypeptides. During the first 5 min after synthesis, the majority of the heavy chains became associated with beta 2-microglobulin. At this stage, the heavy chains carried a high mannose (core) oligosaccharide. Subsequent processing of the oligosaccharide unit occurred during the next 20 to 25 min, resulting in the conversion of the oligosaccharide from the high mannose to the complex form. About 30 to 40 min after synthesis, the mature antigens were expressed at the cell surface. Glycosylation was not required for asymmetric insertion, intracellular transport, or surface expression of the HLA-A and -B antigens. However, studies with Daudi cells indicated that combination with beta 2-microglobulin was necessary for subsequent processing and intracellular transport of the heavy chains after their synthesis in the rough endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000762

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

1.  Glycosylation requirements for intracellular transport and function of the hemagglutinin of influenza virus.

Authors:  P J Gallagher; J M Henneberry; J F Sambrook; M J Gething
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Characterization of two monoclonal antibodies (UCL4D12 and UCL3D3) that discriminate between human mantle zone and marginal zone B cells.

Authors:  J Smith-Ravin; J Spencer; P C Beverley; P G Isaacson
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

3.  Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1.

Authors:  S H Smith; M H Brown; D Rowe; R E Callard; P C Beverley
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

4.  A transcription factor interacting with the class I gene enhancer is inactive in tumorigenic cell lines which suppress major histocompatibility complex class I genes.

Authors:  U Henseling; W Schmidt; H R Schöler; P Gruss; A K Hatzopoulos
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

5.  Intracellular transport blockade caused by disruption of the disulfide bridge in the third external domain of major histocompatibility complex class I antigen.

Authors:  J Miyazaki; E Appella; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

6.  Characterization of a plasma membrane protein present in non-myelin-forming PNS and CNS glia, a subpopulation of PNS neurons, perineurial cells and smooth muscle in adult rats.

Authors:  R Mirsky; J Gavrilovic; P Bannerman; J Winter; K R Jessen
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

7.  Influence of the tapasin C terminus on the assembly of MHC class I allotypes.

Authors:  Laura C Simone; Xiaojian Wang; Amit Tuli; Mary M McIlhaney; Joyce C Solheim
Journal:  Immunogenetics       Date:  2008-10-29       Impact factor: 2.846

8.  Introduction of a human X-6 translocation chromosome into a mouse teratocarcinoma: investigation of control of HLA-A, B, C expression.

Authors:  P N Goodfellow; G Banting; J Trowsdale; S Chambers; E Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

9.  Rapid degradation of the heavy chain of class I major histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells.

Authors:  Y Yamashita; K Shimokata; S Saga; S Mizuno; T Tsurumi; Y Nishiyama
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells.

Authors:  Keith D Tardif; Aleem Siddiqui
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.